Literature DB >> 22807176

Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues.

Erik B Oleson1, Joseph F Cheer.   

Abstract

A growing body of evidence implicates the endocannabinoid (eCB) system in brain reward function. Previous studies show that antagonizing eCB transmission decreases reward-directed behavior and nucleus accumbens (NAc) encoding of reward predictive cues. We, therefore, hypothesized that elevating eCB levels would uniformly facilitate NAc neural encoding of reward predictive cues and reward-directed behavior. Contrary to our expectations, the eCB transport uptake inhibitor, VDM11, dose dependently decreased both measures.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807176      PMCID: PMC3440520          DOI: 10.1002/syn.21587

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  33 in total

1.  Simultaneous dopamine and single-unit recordings reveal accumbens GABAergic responses: implications for intracranial self-stimulation.

Authors:  Joseph F Cheer; Michael L A V Heien; Paul A Garris; Regina M Carelli; R Mark Wightman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-27       Impact factor: 11.205

Review 2.  Cannabinoid CB1 receptors control conditioned drug seeking.

Authors:  Taco J De Vries; Anton N M Schoffelmeer
Journal:  Trends Pharmacol Sci       Date:  2005-08       Impact factor: 14.819

3.  Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.

Authors:  M van der Stelt; C Mazzola; G Esposito; I Matias; S Petrosino; D De Filippis; V Micale; L Steardo; F Drago; T Iuvone; V Di Marzo
Journal:  Cell Mol Life Sci       Date:  2006-06       Impact factor: 9.261

4.  Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.

Authors:  Styliani Vlachou; George G Nomikos; George Panagis
Journal:  Psychopharmacology (Berl)       Date:  2006-09-05       Impact factor: 4.530

5.  Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.

Authors:  Miriam Melis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Beat Lutz; Giovanni Marsicano; Vincenzo Di Marzo; Gian Luigi Gessa; Marco Pistis
Journal:  J Neurosci       Date:  2004-11-24       Impact factor: 6.167

6.  The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys.

Authors:  Zuzana Justinova; Marcello Solinas; Gianluigi Tanda; Godfrey H Redhi; Steven R Goldberg
Journal:  J Neurosci       Date:  2005-06-08       Impact factor: 6.167

7.  Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.

Authors:  Séverine Vandevoorde; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

8.  Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.

Authors:  Shi Di; Cherif Boudaba; Ion R Popescu; Feng-Ju Weng; Christina Harris; Victor L Marcheselli; Nicolas G Bazan; Jeffrey G Tasker
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

9.  Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.

Authors:  Mario van der Stelt; Marcello Trevisani; Vittorio Vellani; Luciano De Petrocellis; Aniello Schiano Moriello; Barbara Campi; Peter McNaughton; Piero Geppetti; Vincenzo Di Marzo
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

10.  Anxiolytic-like properties of the anandamide transport inhibitor AM404.

Authors:  Marco Bortolato; Patrizia Campolongo; Regina Anne Mangieri; Maria Luisa Scattoni; Roberto Frau; Viviana Trezza; Giovanna La Rana; Roberto Russo; Antonio Calignano; Gian Luigi Gessa; Vincenzo Cuomo; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2006-03-15       Impact factor: 7.853

View more
  5 in total

1.  Using dopamine research to generate rational cannabinoid drug policy.

Authors:  G C Loewinger; E B Oleson; J F Cheer
Journal:  Drug Test Anal       Date:  2012-09-19       Impact factor: 3.345

2.  Bi-directional modulation of food habit expression by the endocannabinoid system.

Authors:  Carol A Gianessi; Stephanie M Groman; Jane R Taylor
Journal:  Eur J Neurosci       Date:  2019-01-11       Impact factor: 3.386

Review 3.  Cannabinoid modulation of drug reward and the implications of marijuana legalization.

Authors:  Dan P Covey; Jennifer M Wenzel; Joseph F Cheer
Journal:  Brain Res       Date:  2014-11-25       Impact factor: 3.252

Review 4.  Role of the endogenous cannabinoid system in nicotine addiction: novel insights.

Authors:  Islam Hany Gamaleddin; Jose M Trigo; Aliou B Gueye; Alexander Zvonok; Alexandros Makriyannis; Steven R Goldberg; Bernard Le Foll
Journal:  Front Psychiatry       Date:  2015-03-25       Impact factor: 4.157

Review 5.  Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors.

Authors:  A A A Putri Laksmidewi; Andreas Soejitno
Journal:  J Neural Transm (Vienna)       Date:  2021-03-12       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.